Phreesia Revenue 2019-2025 | PHR

Phreesia revenue from 2019 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Phreesia Annual Revenue
(Millions of US $)
2025 $420
2024 $356
2023 $281
2022 $213
2021 $149
2020 $125
2019 $100
2018 $80
Phreesia Quarterly Revenue
(Millions of US $)
2025-04-30 $116
2025-01-31 $110
2024-10-31 $107
2024-07-31 $102
2024-04-30 $101
2024-01-31 $95
2023-10-31 $92
2023-07-31 $86
2023-04-30 $84
2023-01-31 $77
2022-10-31 $73
2022-07-31 $68
2022-04-30 $63
2022-01-31 $58
2021-10-31 $56
2021-07-31 $51
2021-04-30 $48
2021-01-31 $42
2020-10-31 $38
2020-07-31 $35
2020-04-30 $33
2020-01-31 $33
2019-10-31 $33
2019-07-31 $31
2019-04-30 $28
2019-01-31
2018-10-31 $25
2018-07-31 $25
2018-01-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.732B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.099B 58.65
Tempus AI (TEM) United States $13.629B 0.00
Doximity (DOCS) United States $12.349B 54.94
Hims & Hers Health (HIMS) United States $10.193B 83.52
IRhythm Technologies (IRTC) United States $5.074B 0.00
Hinge Health (HNGE) United States $4.605B 0.00
Privia Health (PRVA) United States $2.623B 194.27
Inspire Medical Systems (INSP) United States $2.613B 38.41
Heartflow (HTFL) $2.433B 0.00
Enovis (ENOV) United States $1.689B 8.93
10x Genomics (TXG) United States $1.676B 0.00
Schrodinger (SDGR) United States $1.476B 0.00
Omnicell (OMCL) United States $1.452B 27.97
Azenta (AZTA) United States $1.394B 60.84
Clover Health Investments (CLOV) United States $1.338B 0.00
Claritev (CTEV) United States $1.189B 0.00
Evolent Health (EVH) United States $1.059B 0.00
Fulgent Genetics (FLGT) United States $0.659B 0.00
Zepp Health (ZEPP) Netherlands $0.630B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Standard BioTools (LAB) United States $0.482B 0.00
Talkspace (TALK) United States $0.435B 130.00
Butterfly Network (BFLY) United States $0.363B 0.00
Carlsmed (CARL) $0.349B 0.00
TruBridge (TBRG) United States $0.290B 50.90
Outset Medical (OM) United States $0.243B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.236B 0.00
Nyxoah SA (NYXH) Belgium $0.224B 0.00
Health Catalyst (HCAT) United States $0.211B 0.00
KORU Medical Systems (KRMD) United States $0.195B 0.00
CapsoVision (CV) United States $0.187B 0.00
MDxHealth SA (MDXH) Belgium $0.141B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.125B 0.00
American Well (AMWL) United States $0.117B 0.00
CareCloud (CCLD) United States $0.115B 5.23
EUDA Health Holdings (EUDA) Singapore $0.098B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.076B 0.00
Pulmonx (LUNG) United States $0.065B 0.00
111 (YI) China $0.062B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
HeartBeam (BEAT) United States $0.041B 0.00
Precipio (PRPO) United States $0.024B 0.00
Zhongchao (ZCMD) China $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.019B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.009B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Evaxion - (EVAX) Denmark $0.005B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00